Successful ABO-incompatible pediatric liver transplantation utilizing standard immunosuppression with selective postoperative plasmapheresis

Liver Transplantation

Volumn 12, Issue 6, 2006, Pages 972-978

  Heffron, Thomas ^a,b,e   Welch, David ^b   Pillen, Todd ^b   Asolati, Massimo ^d   Smallwood, Gregory ^c   Hagedorn, Phil ^b   Nam, Chang ^b   Duncan, Alexander ^a   Guy, Mark ^b   Martinez, Enrique ^a   Spivey, James ^a   Douglas, Patricia ^b   Fasola, Carlos ^a   De Paolo, Jill ^b   Rodriguez, John ^a   Romero, Rene ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Children's Healthcare of Atlanta at Egleston   (United States)

^c EMORY UNIVERSITY HOSPITAL   (United States)

^d VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DACLIZUMAB; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; AGE; ARTICLE; BILE DUCT OBSTRUCTION; BLOOD GROUP ABO INCOMPATIBILITY; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LIVER CIRRHOSIS; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MAXIMUM PERMISSIBLE DOSE; PLASMAPHERESIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; SINGLE DRUG DOSE; SPLENECTOMY; SURVIVAL TIME; TREATMENT OUTCOME;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; BLOOD GROUP INCOMPATIBILITY; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; INFANT; LIVER TRANSPLANTATION; MALE; PLASMAPHERESIS;

EID: 33745491800     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20760     Document Type: Article

References (21)

1. Rydberg L. ABO-incompatibility in solid organ transplantation. Transfus Med 2001;11:325-342.
2. Egawa H, Oike F, Buhler L, Shapiro AM, Minamiguchi S, Haga H, et al. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation 2004:77:403-411.
3. Fang WC, Saltzman J, Rososhansky S, Szabo G, Heard SO, Banner B, et al. Acceptance on an ABO-incompatible mismatched (AB to 0) liver allograft with the use of Dacluzamib and mycophenolate mofetil. Liver Transpl 2000;6:497-500.
4. Farges O, Kalil AN, Samuel D, Saliba F, Arulnaden JL, Debat P, et al. The use of ABO-incompatible grafts in liver transplantation: A life-saving procedure in highly selected patients. Transplantation 1995;59:1124-1133.
5. Farges O, Nocci Kalil A, Samuel D, Arulnaden JL, Bismuth A, Castaing D, et al. Long-term results of ABO-incompatible liver transplantation. Transplant Proc 1995;27:1701-1702.
6. Hanto D, Fecteasu A, Alonso M, Valente JF, Whiting JF. ABO-Incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation. Liver Transpl 2003;9:22-30.
7. Monteiro I, McLaughlin L, Fisher A, de la Torre AN, Koneru B. Rituximab with plasmapheresis and splenectomy in ABO-incompatible liver transplantation. Transplantation 2003;76:1648-1649.
8. Gordon RD, Iwatsuki S, Esquivel CO, Tzakis A, Todo S, Starzl TE. Liver transplantation across ABO blood groups. Surgery 1986;100:342-348.
9. Gugenheim J, Samuel D, Reynes M, Bismuth H. Liver transplantation across ABO blood group barriers. Lancet 1990;336:519-523.
10. Bjoro K, Ericzon B, Kirkegaard P. highly urgent liver transplantation: possible impact of donor-recipient ABO matching on the outcome after transplantation. Transplantation 2003;75:347-353.
11. Stegall M. ABO-incompatible liver transplant: is it justifiable? Liver Transpl 2003;9:31.
12. Varela-Fascinetto G, Treacy SJ, Lillehei CW, Jonas MM, Lund DP, Kevy SV, et al. Long-term results in pediatric ABO-incompatible liver, Transplant Proc 1999;31:467-468.
13. Szymczak M, Kalicinski P, Kaminski A, Ismail H, Drewniak T, Nachulewicz P, et al. Liver transplantation across ABO blood groups in children. Transplant Proc 2003;35:2273-2274.
14. Tanaka A, Tanaka K, Kitai T, Yanabu N, Tokuka A, Sato B, et al. Living related liver transplantation across ABO blood groups. Transplantation 1994;58:548-553.
15. Takayama J, Ohkohchi N, Oikawa K, Asakura T, Kawagishi N, Kikuchi H, et al. Living related liver transplantation in patients with ABO incompatibility. Transplant Proc 1998;30:3504-3506.
16. Gregoire JR. Immune hemolytic anemia after renal transplantation secondary to ABO-minor mismatch between the donor and recipient. J Am Soc Nephrol 1993;4:1122-1126.
17. Hareuveni M, Merchav H, Austerlitz N, Rahimi-Levene N, Ben-Tal O. Donor anti-Jk causing hemolysis in a liver transplant recipient. Transfusion 2002;42:363-367.
18. Panaro F, DeChristopher PJ, Rondelli D, Testa G, Sankary H, Popescu M, et al. Severe hemolytic anemia due to passenger lymphocytes after living-related small bowel transplant (Case Report). Clin Transplant 2004;18:332-335.
19. Heffron TG, Welch D, Pillen T, Fasola C, Redd D, Smallwood GA, et al. Low incidence of hepatic artery thrombosis after pediatric liver transplantation without the use of intraoperative microscope or parenteral anticoagulation. Pediatr Transplant 2005:9:486-490.
20. Guarrera JV, Sinha P, Lobritto SJ, Brown RS Jr, Kinkhabwala M, Emond JC. Microvascular hepatic artery anastomosis in pediatric segmental liver transplantation: microscope vs loupe. Transpl Int 2004;17:585-588.
21. Kim JS, Groteluschen R, Mueller T, Ganschow R, Bicak T, Wilms C. Pediatric transplantation: the Hamburg experience. Transplantation 2005;79:1206-1209.